X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3695) 3695
Book Review (1290) 1290
Publication (462) 462
Book Chapter (31) 31
Book / eBook (30) 30
Conference Proceeding (4) 4
Dissertation (3) 3
Data Set (2) 2
Magazine Article (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3218) 3218
humans (2543) 2543
animals (1757) 1757
programmed cell death 1 receptor - antagonists & inhibitors (1519) 1519
apoptosis (1312) 1312
programmed cell-death (1244) 1244
oncology (965) 965
immunotherapy (937) 937
female (774) 774
cancer (767) 767
male (764) 764
mice (689) 689
cell biology (619) 619
programmed cell death 1 receptor - immunology (548) 548
immunology (526) 526
b7-h1 antigen - antagonists & inhibitors (515) 515
biochemistry & molecular biology (495) 495
antibodies, monoclonal - therapeutic use (488) 488
cell death (448) 448
antineoplastic agents - therapeutic use (441) 441
nivolumab (441) 441
melanoma (430) 430
ctla-4 antigen - antagonists & inhibitors (410) 410
expression (409) 409
pd-1 (393) 393
apoptosis - drug effects (381) 381
middle aged (381) 381
immunotherapy - methods (378) 378
signal transduction (350) 350
apoptosis - physiology (349) 349
ipilimumab (348) 348
programmed cell death 1 receptor - metabolism (347) 347
lymphocytes (336) 336
tumors (332) 332
article (326) 326
aged (324) 324
research (318) 318
care and treatment (314) 314
neurosciences (312) 312
proteins (297) 297
treatment outcome (290) 290
t cells (286) 286
activation (280) 280
adult (278) 278
programmed cell death (276) 276
chemotherapy (275) 275
neoplasms - immunology (274) 274
rats (274) 274
pembrolizumab (272) 272
cells, cultured (270) 270
melanoma - drug therapy (270) 270
health aspects (262) 262
pd-1 protein (261) 261
neoplasms - drug therapy (256) 256
analysis (251) 251
antineoplastic agents - pharmacology (246) 246
cell line, tumor (243) 243
t-cells (235) 235
b7-h1 antigen - immunology (234) 234
immune checkpoint (232) 232
molecular targeted therapy (229) 229
therapy (229) 229
ligands (228) 228
pharmacology & pharmacy (227) 227
lymphocytes t (226) 226
antibodies, monoclonal, humanized - therapeutic use (220) 220
gene expression (218) 218
metastasis (218) 218
survival (218) 218
abridged index medicus (217) 217
mice, inbred c57bl (211) 211
safety (210) 210
t-lymphocytes - immunology (208) 208
open-label (204) 204
in-vivo (203) 203
antibodies, monoclonal - pharmacology (202) 202
patients (202) 202
antineoplastic agents, immunological - therapeutic use (201) 201
pd-l1 (197) 197
b7-h1 antigen - metabolism (193) 193
inflammation (191) 191
physiological aspects (189) 189
blockade (186) 186
multidisciplinary sciences (186) 186
lung neoplasms - drug therapy (184) 184
metastatic melanoma (184) 184
antibodies, monoclonal - adverse effects (183) 183
ctla-4 antigen - immunology (183) 183
signal transduction - drug effects (182) 182
medicine, research & experimental (177) 177
clinical trials as topic (176) 176
hematology (176) 176
cd8-positive t-lymphocytes - immunology (174) 174
caspases - metabolism (173) 173
programmed necrosis (173) 173
necrosis (171) 171
antineoplastic agents - adverse effects (167) 167
cancer therapies (166) 166
prognosis (165) 165
mutation (164) 164
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
UTL at Downsview - May be requested (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Lost (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3669) 3669
French (30) 30
Czech (12) 12
German (12) 12
Chinese (7) 7
Japanese (4) 4
Spanish (4) 4
Danish (3) 3
Polish (2) 2
Swedish (2) 2
Arabic (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 05/2015, Volume 125, Issue 5, pp. 2046 - 2058
T cell Ig and ITIM domain (TIGIT) is an inhibitory receptor expressed by activated T cells, Tregs, and NI( cells. Here, we determined that TIGIT is upregulated... 
MEDICINE, RESEARCH & EXPERIMENTAL | ADHESION MOLECULE | LIGANDS | DNAM-1 | INHIBITORY RECEPTORS | CHRONIC VIRAL-INFECTION | NECTIN-2 CD112 | UP-REGULATION | PVR CD155 | EXPRESSION | POLIOVIRUS RECEPTOR CD155 | Up-Regulation | Receptors, Immunologic - physiology | Receptors, Virus - biosynthesis | Humans | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Neoplasm Proteins - antagonists & inhibitors | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Programmed Cell Death 1 Receptor - physiology | Receptors, Virus - genetics | Receptors, Immunologic - antagonists & inhibitors | Receptors, Immunologic - biosynthesis | Programmed Cell Death 1 Receptor - biosynthesis | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Interleukin-2 Receptor beta Subunit - genetics | Neoplasm Proteins - genetics | Antibodies, Monoclonal - immunology | Antigen-Presenting Cells - metabolism | Antigens, Neoplasm - immunology | Lymphocyte Activation | Neoplasm Proteins - biosynthesis | Antibodies, Monoclonal - pharmacology | Immunophenotyping | Interleukin-2 Receptor beta Subunit - biosynthesis | Melanoma - pathology | Antigen-Presenting Cells - immunology | Melanoma - immunology | Antigens, Differentiation, T-Lymphocyte - genetics | Cell Line, Tumor | T-Cell Antigen Receptor Specificity | Immunologic Memory | Antigens, Differentiation, T-Lymphocyte - biosynthesis | CD8-Positive T-Lymphocytes - immunology | Receptors, Immunologic - genetics | Programmed Cell Death 1 Receptor - genetics | Cytokines - biosynthesis | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | Abridged Index Medicus | Oncology | Immunology | Dermatology | Therapeutics
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2015, Volume 10, Issue 6, pp. 910 - 923
Epidermal growth factor receptor (EGFR) mutation status was reported to be associated with programmed death-ligand 1 (PD-L1) expression. However, the molecular... 
PD-L1 | NSCLC | PD-1 | EGFR | Tyrosine kinase inhibitors | LUNG | CELLS | B7-H1 EXPRESSION | DEATH-LIGAND 1 | MELANOMA | ONCOLOGY | PATHWAY | IMMUNOTHERAPY | RESPIRATORY SYSTEM | POOR-PROGNOSIS | GROWTH | INHIBITORS | Tumor Escape - drug effects | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Sequence Deletion | Up-Regulation | Exons | Humans | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Molecular Targeted Therapy | Receptor, Epidermal Growth Factor - metabolism | T-Lymphocytes - pathology | Lung Neoplasms - genetics | Receptor, Epidermal Growth Factor - immunology | Lung Neoplasms - enzymology | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Programmed Cell Death 1 Receptor - metabolism | B7-H1 Antigen - genetics | B7-H1 Antigen - immunology | Carcinoma, Non-Small-Cell Lung - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Apoptosis - immunology | B7-H1 Antigen - antagonists & inhibitors | Interferon-gamma - immunology | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | T-Lymphocytes - immunology | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Interferon-gamma - biosynthesis | Index Medicus
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7, pp. 709 - 717
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2255 - 2266
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 12/2014, Volume 23, Issue 12, pp. 2965 - 2970
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facilitating disease progression. Preliminary clinical trials... 
SURVIVAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | B7-H1 PD-L1 | MELANOMA | ONCOLOGY | SAFETY | POOR-PROGNOSIS | ANTI-PD-1 | HUMAN BREAST-CANCER | EXPRESSION | CARCINOMA | LYMPHOCYTES | Prognosis | Neoplasms - genetics | Humans | Female | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Disease Progression | Index Medicus
Journal Article
Journal Article
Nature, ISSN 0028-0836, 11/2014, Volume 515, Issue 7528, pp. 568 - 571
Journal Article